Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 3Classical hematology 3Lymphoid 2Myeloid 1CNS 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 55Leukemia, Myeloid, Acute 54Myelodysplastic Syndromes 47Leukemia 36Lymphoma, Non-Hodgkin 34Lymphoma 32Breast Neoplasms 29Leukemia, Myelogenous, Chronic, BCR-ABL Positive 25Central Nervous System Neoplasms 21Hematologic Neoplasms 20Hodgkin Disease 19Neuroblastoma 18Leukemia, Lymphocytic, Chronic, B-Cell 17Burkitt Lymphoma 15Multiple Myeloma 14Medulloblastoma 14Leukemia, Myeloid, Accelerated Phase 13Leukemia, Biphenotypic, Acute 13Brain Neoplasms 13Lymphoma, Large B-Cell, Diffuse 12Blast Crisis 12Graft vs Host Disease 11Congenital Abnormalities 11Myeloproliferative Disorders 10Lymphoma, Large-Cell, Immunoblastic 10Lymphoma, Follicular 10Dendritic Cell Sarcoma, Interdigitating 10Astrocytoma 10Anemia, Refractory, with Excess of Blasts 10Recurrence 9

Interventions

fludarabine phosphate 5fludarabine 4Whole-Body Irradiation 4Melphalan 4Cyclophosphamide 4Thiotepa 3Busulfan 3Blood Specimen Collection 3Antilymphocyte Serum 3Alemtuzumab 3plerixafor 2Therapeutics 2Cyclosporins 2Cyclosporine 2thymoglobulin 1fosphenytoin 1Voriconazole 1Vaccination 1Tacrolimus 1Photopheresis 1Phlebotomy 1Phenytoin 1Peripheral Blood Stem Cell Transplantation 1Mycophenolic Acid 1Mesna 1Injections 1Influenza Vaccines 1Honey 1Holistic Health 1Granulocyte Colony-Stimulating Factor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Immunologic Deficiency Syndromes × Thiotepa × Clear all
NCT03609840 2023-09-21

Study of Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients

University of California, San Francisco

Completed
25 enrolled
Classical hematologyOther hematologic neoplasm

Anemia, Sickle Cell, Fanconi Anemia, Hemoglobinopathies, Immunologic Deficiency Syndromes, Thalassemia, Hematologic Neoplasms

NCT00801931 2019-03-27

Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders

Columbia University

Phase 1/2 Terminated
1 enrolled 8 charts
CNSClassical hematologyLymphoidOther hematologic neoplasm

Anemia, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Neuroblastoma

NCT01049854 2018-08-21

CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant

New York Medical College

Phase 2 Completed
20 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Sickle Cell, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Metabolism, Inborn Errors, Histiocytosis, beta-Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡